These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1887040)

  • 41. T1 and T2 relaxometry of monocrystalline iron oxide nanoparticles (MION-46L): theory and experiment.
    Bulte JW; Brooks RA; Moskowitz BM; Bryant LH; Frank JA
    Acad Radiol; 1998 Apr; 5 Suppl 1():S137-40; discussion S145-6. PubMed ID: 9561064
    [No Abstract]   [Full Text] [Related]  

  • 42. Relaxometry and magnetometry of the MR contrast agent MION-46L.
    Bulte JW; Brooks RA; Moskowitz BM; Bryant LH; Frank JA
    Magn Reson Med; 1999 Aug; 42(2):379-84. PubMed ID: 10440963
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Application of a stable cell culture assay for the functional assessment of novel MR contrast agents.
    Reimer P; Bader A; Weissleder R
    Eur Radiol; 1997; 7(4):527-31. PubMed ID: 9204333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Steady-state MR imaging with MION for quantification of angiogenesis in normal brain and in brain tumors.
    Dunn JF; Roche MA; Springett R; Abajian M; Merlis J; Daghlian CP; Lu SY; O'Hara JA; Makki M
    Adv Exp Med Biol; 2003; 540():221-6. PubMed ID: 15174624
    [No Abstract]   [Full Text] [Related]  

  • 45. Early identification of aortic valve sclerosis using iron oxide enhanced MRI.
    Hamilton AM; Rogers KA; Belisle AJ; Ronald JA; Rutt BK; Weissleder R; Boughner DR
    J Magn Reson Imaging; 2010 Jan; 31(1):110-6. PubMed ID: 20027578
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potential of superparamagnetic iron oxide in the differential diagnosis of metastasis and inflammation in bone marrow: experimental study.
    Tsuda N; Tsuji T; Kato N; Fukuda Y; Ando K; Ishikura R; Nakao N
    Invest Radiol; 2005 Oct; 40(10):676-81. PubMed ID: 16189437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran-magnetite particles.
    Bulte JW; Ma LD; Magin RL; Kamman RL; Hulstaert CE; Go KG; The TH; de Leij L
    Magn Reson Med; 1993 Jan; 29(1):32-7. PubMed ID: 7678318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ferromagnetic particles as contrast agents for magnetic resonance imaging of liver and spleen.
    Mendonca Dias MH; Lauterbur PC
    Magn Reson Med; 1986 Apr; 3(2):328-30. PubMed ID: 3713497
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of field strength and iron oxide nanoparticle concentration on the linearity and diagnostic accuracy of off-resonance imaging.
    Farrar CT; Dai G; Novikov M; Rosenzweig A; Weissleder R; Rosen BR; Sosnovik DE
    NMR Biomed; 2008 Jun; 21(5):453-63. PubMed ID: 17918777
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New perspectives on bone marrow contrast agents and molecular imaging.
    Daldrup-Link HE; Mohanty A; Cuenod C; Pichler B; Link T
    Semin Musculoskelet Radiol; 2009 Jun; 13(2):145-56. PubMed ID: 19455477
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Labeling of stem cells with monocrystalline iron oxide for tracking and localization by magnetic resonance imaging.
    Li Calzi S; Kent DL; Chang KH; Padgett KR; Afzal A; Chandra SB; Caballero S; English D; Garlington W; Hiscott PS; Sheridan CM; Grant MB; Forder JR
    Microvasc Res; 2009 Jun; 78(1):132-9. PubMed ID: 19345699
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polycationic nanoparticles: (1) synthesis of a polylysine-MION conjugate and its application in labeling fibroblasts.
    Groman EV; Yang M; Reinhardt CP; Weinberg JS; Vaccaro DE
    J Cardiovasc Transl Res; 2009 Mar; 2(1):30-8. PubMed ID: 20559967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization and in vivo distribution of 99mTc- and 111In-labelled magnetite.
    Bligh SW; Sadler PJ; Marriott JA; Latham IA; Kelly JD
    Int J Rad Appl Instrum A; 1989; 40(9):751-7. PubMed ID: 2559064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of acute inflammation with 111In-labeled nonspecific polyclonal IgG.
    Fischman AJ; Rubin RH; Khaw BA; Callahan RJ; Wilkinson R; Keech F; Nedelman M; Dragotakes S; Kramer PB; LaMuraglia GM
    Semin Nucl Med; 1988 Oct; 18(4):335-44. PubMed ID: 3212469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improvement of MRI probes to allow efficient detection of gene expression.
    Högemann D; Josephson L; Weissleder R; Basilion JP
    Bioconjug Chem; 2000; 11(6):941-6. PubMed ID: 11087345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Magnetic nanoparticles for MRI of brain tumors.
    Wang J; Huang Y; David AE; Chertok B; Zhang L; Yu F; Yang VC
    Curr Pharm Biotechnol; 2012 Sep; 13(12):2403-16. PubMed ID: 23016645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transcellular Transport of Heparin-coated Magnetic Iron Oxide Nanoparticles (Hep-MION) Under the Influence of an Applied Magnetic Field.
    Min KA; Yu F; Yang VC; Zhang X; Rosania GR
    Pharmaceutics; 2010 Apr; 2(2):119-135. PubMed ID: 21152371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Usefulness of Scintigraphic Studies in the Assessment of Asymptomatic Bowel Disease in Patients with Primary Antibody Diseases.
    Milito C; Cinetto F; Megna V; Spadaro G; Quinti I; Liberatore M
    J Clin Med; 2020 Mar; 9(4):. PubMed ID: 32235478
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of indium intoxication by ferric dextran.
    GABBIANI G; SELYE H; TUCHWEBER B
    Br J Pharmacol Chemother; 1962 Dec; 19(3):508-12. PubMed ID: 13945982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Magnetic protein imprinted polymers: a review.
    Boitard C; Bée A; Ménager C; Griffete N
    J Mater Chem B; 2018 Mar; 6(11):1563-1580. PubMed ID: 32254273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.